BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 29901696)

  • 1. RNA interference targeting CD147 inhibits metastasis and invasion of human breast cancer MCF-7 cells by downregulating MMP-9/VEGF expression.
    Li F; Zhang J; Guo J; Jia Y; Han Y; Wang Z
    Acta Biochim Biophys Sin (Shanghai); 2018 Jul; 50(7):676-684. PubMed ID: 29901696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Impact of siRNA-mediated down-regulation of CD147 on human breast cancer cells].
    Li Z; Li D; Li J; Huang P; Qin H
    Zhonghua Bing Li Xue Za Zhi; 2015 Oct; 44(10):734-8. PubMed ID: 26702532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lentivirus mediated RNA interference of EMMPRIN (CD147) gene inhibits the proliferation, matrigel invasion and tumor formation of breast cancer cells.
    Yang J; Wang R; Li H; Lv Q; Meng W; Yang X
    Cancer Biomark; 2016 Jul; 17(2):237-47. PubMed ID: 27434292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA interference targeting extracellular matrix metalloproteinase inducer (CD147) inhibits growth and increases chemosensitivity in human cervical cancer cells.
    Zhang F; Zeng YL; Zhang XG; Chen WJ; Yang R; Li SJ
    Eur J Gynaecol Oncol; 2013; 34(5):429-35. PubMed ID: 24475577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD147 depletion down-regulates matrix metalloproteinase-11, vascular endothelial growth factor-A expression and the lymphatic metastasis potential of murine hepatocarcinoma Hca-F cells.
    Jia L; Cao J; Wei W; Wang S; Zuo Y; Zhang J
    Int J Biochem Cell Biol; 2007; 39(11):2135-42. PubMed ID: 17693120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A regulatory loop involving miR-22, Sp1, and c-Myc modulates CD147 expression in breast cancer invasion and metastasis.
    Kong LM; Liao CG; Zhang Y; Xu J; Li Y; Huang W; Zhang Y; Bian H; Chen ZN
    Cancer Res; 2014 Jul; 74(14):3764-78. PubMed ID: 24906624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNAi-mediated silencing of CD147 inhibits tumor cell proliferation, invasion and increases chemosensitivity to cisplatin in SGC7901 cells in vitro.
    Wang B; Xu YF; He BS; Pan YQ; Zhang LR; Zhu C; Qu LL; Wang SK
    J Exp Clin Cancer Res; 2010 Jun; 29(1):61. PubMed ID: 20525232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (-)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells.
    Farabegoli F; Papi A; Orlandi M
    Biosci Rep; 2011 Apr; 31(2):99-108. PubMed ID: 20446926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of basigin expression in glioblastoma cell line via antisense RNA reduces tumor cell invasion and angiogenesis.
    Liang Q; Xiong H; Gao G; Xiong K; Wang X; Zhao Z; Zhang H; Li Y
    Cancer Biol Ther; 2005 Jul; 4(7):759-62. PubMed ID: 15970688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of CD147 expression reduces tumor cell invasion in human prostate cancer cell line via RNA interference.
    Wang L; Wu G; Yu L; Yuan J; Fang F; Zhai Z; Wang F; Wang H
    Cancer Biol Ther; 2006 Jun; 5(6):608-14. PubMed ID: 16627983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD147 promotes breast cancer migration and invasion by inducing epithelial-mesenchymal transition via the MAPK/ERK signaling pathway.
    Li F; Wang J; Yan YQ; Bai CZ; Guo JQ
    BMC Cancer; 2023 Dec; 23(1):1214. PubMed ID: 38066486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A CD147-targeting siRNA inhibits the proliferation, invasiveness, and VEGF production of human malignant melanoma cells by down-regulating glycolysis.
    Su J; Chen X; Kanekura T
    Cancer Lett; 2009 Jan; 273(1):140-7. PubMed ID: 18778892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FoxM1 down-regulation leads to inhibition of proliferation, migration and invasion of breast cancer cells through the modulation of extra-cellular matrix degrading factors.
    Ahmad A; Wang Z; Kong D; Ali S; Li Y; Banerjee S; Ali R; Sarkar FH
    Breast Cancer Res Treat; 2010 Jul; 122(2):337-46. PubMed ID: 19813088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of matrix metalloproteinase (MMP)-2 and -9 and vascular endothelial growth factor C in lymph node metastasis of breast cancer].
    Zheng SQ; Huang RQ; Zhang YJ
    Zhonghua Bing Li Xue Za Zhi; 2010 Apr; 39(4):240-4. PubMed ID: 20654122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S100A4 silencing suppresses proliferation, angiogenesis and invasion of thyroid cancer cells through downregulation of MMP-9 and VEGF.
    Jia W; Gao XJ; Zhang ZD; Yang ZX; Zhang G
    Eur Rev Med Pharmacol Sci; 2013 Jun; 17(11):1495-508. PubMed ID: 23771538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repressing CD147 is a novel therapeutic strategy for malignant melanoma.
    Hu X; Su J; Zhou Y; Xie X; Peng C; Yuan Z; Chen X
    Oncotarget; 2017 Apr; 8(15):25806-25813. PubMed ID: 28445958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Construction of a CD147 lentiviral expression vector and establishment of its stably transfected A549 cell line].
    Yang S; Tang C; Wang S; Song S; Liu X
    Zhongguo Fei Ai Za Zhi; 2012 Dec; 15(12):694-700. PubMed ID: 23249715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VEGF/NRP-1axis promotes progression of breast cancer via enhancement of epithelial-mesenchymal transition and activation of NF-κB and β-catenin.
    Luo M; Hou L; Li J; Shao S; Huang S; Meng D; Liu L; Feng L; Xia P; Qin T; Zhao X
    Cancer Lett; 2016 Apr; 373(1):1-11. PubMed ID: 26805761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GALNT14 mediates tumor invasion and migration in breast cancer cell MCF-7.
    Huanna T; Tao Z; Xiangfei W; Longfei A; Yuanyuan X; Jianhua W; Cuifang Z; Manjing J; Wenjing C; Shaochuan Q; Feifei X; Naikang L; Jinchao Z; Chen W
    Mol Carcinog; 2015 Oct; 54(10):1159-71. PubMed ID: 24962947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of CD147, matrix metalloproteinases and transforming growth factor beta1 in breast cancer].
    Xue S; Li SX; Wu ZS; Wang XN; Wu Q; Yang F
    Zhonghua Bing Li Xue Za Zhi; 2009 Aug; 38(8):524-8. PubMed ID: 20021962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.